PRESS RELEASE

MIKA/PR/001/VI/2020

Jakarta, June 24, 2020 – PT Mitra Keluarga Karyasehat Tbk (“MIKA” atau “Perseroan”) will distribute cash dividend of Rp 299.7 billion or Rp. 21 per share. Dividends distributed are equivalent to a dividend payout ratio of around 40.97% of net income for the 2019 fiscal year. This dividend distribution has obtained approval from the Company's shareholders who were present at the Company's Annual General Meeting of Shareholders ("AGMS") held on June 24, 2020 located at Mitra Keluarga Kelapa Gading Hospital, Jakarta. In compliance with the prevailing regulations, dividend payment will be made at the latest within 30 days after the announcement of AGMS where the Company will shortly announce the schedule and procedures.

In the AGMS, the Company has also obtained the approval of the shareholders on several things as follows:

1. Approval of Company's Annual Report for the fiscal year ending December 31, 2019, including the Company's Activity Report, the Board of Commissioners Supervisory Task Report and the financial year report ended on December 31, 2019, as well as providing full repayment and release fully answer (acquit et de charge) to the Directors and Board of Commissioners of the Company for their management and supervision actions in the fiscal year ending December 31, 2019 as long as those actions are reflected in the Annual Report.
2. Approve the use of the Company's net profit for the year ending December 31, 2019 as follows:
   1. Distributed as cash dividends of Rp. 21 per share to shareholders, which is listed on the Company's shareholders list on the recording date (recording date) which will be determined by the Directors, taking into account applicable tax regulations;
   2. 7,301,450,810 (seven billion three hundred one million four hundred fifty thousand eight hundred and ten rupiah), allocated and recorded as a reserve fund;
   3. The rest is recorded as retained earnings, to increase the Company's working capital.
3. To grant power and authority to the Directors of the Company to take any and all necessary actions in connection with the above-mentioned decision, in accordance with the applicable laws and regulations.
4. Receives and approves the report on the use of proceeds from the Company's Initial Public Offering.
5. To appoint the composition of the Company's Board of Commissioners as of the closing of this Meeting until the closing of the Annual General Meeting of Shareholders of the Company in 2023, is as follows:

Board of Directors:
President Director        : Mr. Rustiyan Oen
Director                      : Ms. Joyce Vidyayanti Handajani
Director                      : Ms. Esther Maria Ramono

Board of Commissioners:
President Commissioner       : Mr. Jozef Darmawan Angkasa
Independent Commissioner   : Mr. Johannes Setijono
Independent Commissioner   : Mr. I Gusti Gede Subawa

6. Give authority and power to the Directors of the Company, with the right of substitution, to pour / state the decision regarding the composition of the Directors and Board of Commissioners of the Company in the deed made before a Notary, and henceforth notify it to the authorities, and take all and every action which is needed in connection with the decision in accordance with the applicable laws and regulations.
7. Approve and determine the salary and / or honorarium for the members of the Board of Commissioners of the Company as a whole for fiscal year 2020 not to exceed 1% of the total net income of the Company in 2019, and give the Board of Commissioners the authority to determine their allocations, taking into account input / recommendation from the Nomination and Remuneration Committee.
8. Gives authority to the Company's Board of Commissioners to determine salary and / or benefits for members of the Company's Board of Directors, taking into account input / recommendations from the Company's Nomination and Remuneration Committee.
9. Giving authority and power to the Board of Commissioners of the Company, to appoint a Public Accountant, with Independent criteria and registered with the Financial Services Authority, which will audit the Company's financial statements for the fiscal year ending on December 31, 2020, because they are being considered and evaluated for the appointment of a further Public Accountant, as well as to determine the honorarium of the Public Accountant, and to determine the conditions for the appointment including termination.

The Company also conduct Extraordinary General Meeting Shareholders (“EGMS”) and obtained the approval of the shareholders on several things as follows:

1. Approved the amendment and restatement of the Company's Articles of Association in the context of adjusting to the Financial Services Authority Regulation Number 15 / POJK.04 / 2020 concerning the Plans and Organizing of a Public Company General Meeting of Shareholders, which was explained at the Meeting.
2. Approve to give authority and power to the Directors of the Company, both individually and jointly, with the right of substitution, to take all and every action needed in connection with the said decision, including but not limited to stating / pouring the said decision in the deed -acta made before a Notary, to amend and / or rearrange all the provisions of the Company's Articles of Association in accordance with the decision (including confirming the composition of the shareholders in the deed when necessary), as required by and in accordance with applicable laws and regulations, which then to submit an application for approval and / or deliver notification of the decision of this Meeting and / or amendment to the Company's Articles of Association in the decision of this Meeting, to the competent authority, and to take all and every necessary action, in accordance with the applicable laws and regulations.
3. Approve to give authority and power to the Directors of the Company, both individually and jointly, with the right of substitution, to take all and every action needed in connection with the decision, including but not limited to stating / pouring the decision in the deed -acta made before a Notary, to amend and / or rearrange all the provisions of the Company's Articles of Association in accordance with the decision (including confirming the composition of the shareholders in the deed when necessary), as required by and in accordance with applicable laws and regulations, which then to submit an application for approval and / or deliver notification of the decision of this Meeting and / or amendment to the Company's Articles of Association in the decision of this Meeting, to the competent authority, and to take all and every necessary action, in accordance with the applicable laws and regulations.
4. To approve the change in the type of the Company from foreign investment to domestic investment.
5. Approve to give authority and power to the Directors of the Company, both individually and jointly, with the right of substitution, to carry out all and every action needed in connection with the decision, including but not limited to declaring / pouring the decision in the deed which is made before a Notary, who then notifies the competent authority, and takes all and every action required in connection with the said decision in accordance with the applicable laws and regulations.

Mitra Keluarga Karyasehat Tbk at a glance

The Company built its first hospital back in 1989 and currently owns and operates 24 hospitals, sixteen of which are located in the Greater Jakarta area, four in West Java, three in Surabaya (East Java), and one in Tegal (Central Java) Normally, the hospitals are equipped with emergency rooms, outpatient clinics, inpatient wards, operating rooms, intensive care units and a pharmacy, as well as laboratory and radiology facilities. The hospitals also offer specialized services such as obstetrics, pediatrics, internal medicine, angioplasty, orthopedic surgery and neurosurgery, amongst others.

From its humble beginnings, The Company has transformed into one of Indonesia’s biggest private hospital operators by an intake of 2.8 million patients in 2019 and in terms of hospital bed capacity with 2,876 operational beds as of December 31, 2019

The Company employed more than 7,794 medical professionals including doctors, laboratory staff, nurses and therapists with around 1,251 specialists practicing in all of its hospitals by 2019.

The Company successfully listed its shares in the Indonesia Stock Exchange on March 24, 2015. With 18.0% free-float, the Company has a market capitalization of IDR 28 trillion as of December 31, 2019. (IDX:MIKA).